More than 150 countries engaged in COVID-19 vaccine global access initiative


  • Heather Mason
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

The World Health Organization (WHO) has announced that 75 countries have submitted expressions of interest to protect their populations and those of other nations by joining the COVAX Facility. This aims to guarantee rapid, fair and equitable access to COVID-19 vaccines worldwide, and sharing the risks associated with vaccine development.

These 75 countries will finance vaccines through their own public budgets, and partner with 90 lower-income countries that could be supported through the Vaccine Alliance Gavi’s financing instrument, the COVAX Advance Market Commitment (AMC), launched in June. These 165 countries make up over 60 per cent of the global population, offering a "tremendous vote of confidence" in the effort to ensure global access to COVID-19 vaccines, the WHO says.

The AMC has already raised over €500 million (US$ 600 million) against an initial target of €1.75 billion (US$ 2 billion) from high-income donors and the private sector. The Gavi Alliance will also work with developing countries to assure the readiness of supply and cold chain and training to reach high-risk groups.

The COVAX Facility forms a key part of the COVAX pillar of the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.